Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Third party request |
| Strategy: | Combo: DNA, protein & vector vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2013-07-17 |
| Study Made Public: | 2013-11-08 |
Title
DNA and Adenovirus Prime alters ALVAC/gp120 vaccine efficacy
Description
CAVD 419 is a non-human primate challenge study comparing immune responses in DNA/ALVAC-protein and Ad26/ALVAC-protein prime/boost regimens.
Sign in to see full information about this study and to download study data.